QLY Biotech Group (QLY Biotech Group) Change In Working Capital : $0.01 Mil (TTM As of Feb. 2023)

View and export this data going back to 2021. Start your Free Trial

What is QLY Biotech Group Change In Working Capital?

QLY Biotech Group's change in working capital for the quarter that ended in Feb. 2023 was $0.00 Mil.

QLY Biotech Group's change in working capital for the fiscal year that ended in Aug. 2022 was $-0.00 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

QLY Biotech Group Change In Working Capital Historical Data

The historical data trend for QLY Biotech Group's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QLY Biotech Group Change In Working Capital Chart

QLY Biotech Group Annual Data

Trend

Aug19

Aug20

Aug21

Aug22

Change In Working Capital

QLY Biotech Group Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23
Change In Working Capital	Get a 7-Day Free Trial												-	-	-	-	-

QLY Biotech Group Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Feb. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

QLY Biotech Group Change In Working Capital Related Terms

Thank you for viewing the detailed overview of QLY Biotech Group's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

QLY Biotech Group (QLY Biotech Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » QLY Biotech Group Corp (OTCPK:LQLY) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

5348 Vegas Drive, Las Vegas, NV, USA, 89108

Website

QLY Biotech Group Corp is a United States based company engaged in the tourism business.

QLY Biotech Group (QLY Biotech Group) Headlines

No Headlines